RespiratoryDX™

RespiratoryDX™ uses advanced molecular technology to detect 31 respiratory targets from a single sample, delivering clear, actionable results when they matter most.

COVID PlusDX™ is a multiplex molecular assay that detects SARS-CoV-2, Influenza A/B, RSV A/B, and Streptococcus pneumoniae in a single test. Rapid, comprehensive results help clinicians differentiate respiratory infections and guide appropriate treatment and infection control decisions. 

Strep-ADX™ is a rapid molecular test for the detection of Streptococcus pyogenes (Group A Strep). This highly sensitive assay provides accurate results to support timely diagnosis and appropriate antibiotic treatment, improving patient care and clinical efficiency.